source
- ARPA-H selects UpDoc, Tempus AI and Atman Health for new AI heart-disease programARPA-H announced a new initiative called ADVOCATE that will bring together three companies to develop AI-driven tools for managing heart disease. The selected firms - UpDoc, Tempus AI, and Atman H…
- Beeline Medicines reports promising Phase 2 lupus dataBeeline Medicines, a Bain‑backed startup, announced encouraging mid‑stage results for its lupus candidate afimetoran, a drug originally sourced from Bristol Myers Squibb. The Phase 2 trial data we…